Back close

Mycobacterium tuberculosis treatment modalities and recent insights

Publication Type : Journal Article

Thematic Areas : Nanosciences and Molecular Medicine

Publisher : Current drug delivery, Bentham Science Publishers

Source : Current drug delivery, Bentham Science Publishers, Volume 11, Number 6, p.744–752 (2014)

Url :

Keywords : Antibiotics; cytokines; immune response; intracellular pathogen; macrophages; nanoparticles; tuberculosis

Campus : Kochi

School : Center for Nanosciences

Center : Amrita Center for Nanosciences and Molecular Medicine Move, Nanosciences

Department : Nanosciences and Molecular Medicine

Year : 2014

Abstract : Antimicrobial therapy of infections caused by M. tuberculosis is a challenge due to poor response to therapy and recurrent infections. Under in vitro conditions, antibiotics effectively kill M. tuberculosis within the first two weeks. However, an extended treatment time of 6-9 months is required to eradicate M. tuberculosis infection, mainly due to the intracellular survival of this pathogen and poor penetration of the antibiotics into the intracellular compartment of the host cells. Recent advances in the field of drug delivery have led to the use of different antibiotic incorporated nano- and micro- formulations such as liposomes, polymeric particles, mesoporous silica particles and particulate suspensions for targeted drug delivery applications into the intracellular compartment of the macrophages. The drug incorporated nano- and micro-particles are prone to be easily internalized, which leads to preferential delivery of the drugs into the tissues and organs of interest. Other advantages of these nano- and micro-particles over the free drugs are their comparatively higher stability and bioavailability. This review highlights the current strategies and challenges in treatment, the different antibiotics available, their modes of action, generation and mechanism of drug resistance and recent advances in the intracellular drug delivery using nanoparticles for the treatment of tuberculosis.

Cite this Research Publication : V. Sukhithasri, Vinod, V., Varma, S., and Dr. Raja Biswas, “Mycobacterium tuberculosis treatment modalities and recent insights”, Current drug delivery, vol. 11, pp. 744–752, 2014.

Admissions Apply Now